Checkmate 238: Adjuvant checkpoint therapy after melanoma resection
11 Sep 2017
Checkmate 238: Adjuvant checkpoint therapy after melanoma resection
The METRIC trial of trametinib, five years on
New strategies in melanoma care
Reduced work ability in cancer survivors
Problems with survivorship care in Europe
Underprovision and inequality of specialised cancer care
Editor's Choice for August 2017
Editor's Choice for July 17
iManageCancer: Serious Games for Kids
The unmet needs of cancer survivors
Precision medicine: a nurses perspective
New drug advancements presented at ASCO